Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Illumina Eyes Japan Launch of Comprehensive Genomic Profiling Test This Year
March 16, 2023
- Paxlovid to Enter Normal Distribution from March 22: Pfizer Japan
March 16, 2023
- Ono, PeptiDream in Deal for Macrocyclic Constrained Peptide Therapeutics
March 16, 2023
- Iron Solution MonoVer Now Available in Japan; Donepezil Patch, Cresemba to Hit Market in April
March 16, 2023
- Teijin Pharma Plans Pivot to Rare Diseases as Generics Eat into Feburic Sales
March 15, 2023
- Xtandi Hits Mark in China HSPC Study to Pave Way for Label Expansion
March 15, 2023
- Takeda’s Dengue Vaccine Approved in Brazil
March 15, 2023
- Eisai’s Leqembi Wins Coverage from US Veteran’s Body
March 15, 2023
- Bayer Setting Out to Cut Up to 480 Jobs as Xarelto Patent Cliff Looms: Employee
March 14, 2023
- Japan’s Non-COVID Jab Market to Surpass 180 Billion Yen by 2030: Fuji Keizai
March 14, 2023
- Moderna, Tohoku University Link Up for Next-Gen Healthcare
March 14, 2023
- Shionogi Inks Malaria Drug Collab with Nagasaki University, MMV
March 14, 2023
- Serious Side Effect Cases Total 8: Xocova Safety Update
March 13, 2023
- Padcev Application Accepted for Review in China: Astellas
March 13, 2023
- AstraZeneca Looks to 1st IO/ADC Launch as Leader in the Race: Oncology Head
March 13, 2023
- Eisai Eyes 1 Trillion Yen in Leqembi Global Sales in FY2030: CEO
March 10, 2023
- Xospata Fails in PIII for Post-Transplant AML Maintenance Therapy: Astellas
March 10, 2023
- Shingo Iwamoto Sworn in as New Chief of Nichi-Iko; Tamura Bows Out
March 9, 2023
- Silgard 9 Approved for 2-Dose Schedule: MSD
March 9, 2023
- Nipro Curbed Shipments of 28 APIs/40 Products as Precaution for Rush Demand
March 9, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…